xi'an chukang biotechnology co.,ltd
xi'an chukang biotechnology co.,ltd
Shaanxi, China

COMPANY OVERVIEW

Company Album

Basic Information
Xi'an Chukang Biotechnology Co.,Ltd bound with the concept of faithful service and professional innovation,has dedicated to the identification, development and production of active constituents from natural products, and supplied materials for Pharmaceutical, food, health care, cosmetic industries since 2006.At present, it is a leading manufacturer,and exporter in American,with annualsales above 15 million MT. Situated in East High-tech Development Zone, Xi'an Chukang Biotechnology Co.,Ltd holds a powerful R& D team which consists of doctorial supervisors,professors,doctors and masters.Based on the modernized,rigorous and innovative management, abundant herbal resources in Qinling Mountain and worldwide supply bases of quality raw material,it has developed over a hundred kinds of products and specially enjoyed prominent advantages at Paclitaxel,5-HTP, CoenzymeQ10,blueberry P.E.Flax seedP.E Phosphatidylserine,Genistein, Ginkgo Biloba P.E. Green Coffee Powder Extract,Valerian,Root P.E.Citrus Aurantium P. E. Kava Kava P. E. White Willow P. E.Osthole P.E.Epimedium P.E And etc in the country. Xi'an Chukang Biotechnology Co.,Ltd possesses a global business network covering more than 30 countries and regions in Europe, America, and Asia.It aims to constantly innovate the professional technology,serve the customers as excellent manufacturer of natural products,and meanwhile, upgrade and transform the traditional Chinese herbal medicines to introduce it to the rest of the world.Cooperation brings property. Xi'an Chukang Biotechnology Co.,Ltd is always the most faithful partner in your pursuit to success.
  • Transactions
    -

TRADE CAPABILITIES

Main Markets & Product(s)

Main markets
Total Revenue(%)
Main Product(s)
Verified
North America
8.33%
South America
8.33%
Eastern Europe
8.33%
Southeast Asia
8.33%
Africa
8.33%
Oceania
8.33%
Mid East
8.33%
Eastern Asia
8.33%
Western Europe
8.33%
Central America
8.33%
Northern Europe
8.33%
Southern Europe
8.33%
Verified

Trade Ability

Total Annual Revenue
US$50 Million - US$100 Million